Adaptive Phage Therapeutics Announces Strategic Agreement with ARLG to Support Phase 1b/2 Cystic Fibrosis Study

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www.aphage.com/adaptive-phage-therapeutics-announces-strategic-agreement-with-arlg-to-support-phase-1b-2-cystic-fibrosis-study/
Research Institution
Adaptive Phage Therapeutics
Short Title
Adaptive Phage Therapeutics Announces Strategic Agreement with ARLG to Support Phase 1b/2 Cystic Fibrosis Study
Content Coordinator
Claudia Wair
Content Manager
Catey Laube Macdonald